Dongbao Bio-Tech fell 6.5% due to fundraising management violations receiving "double letters"
Dongbao Bio-Tech is currently down 6.5% at HKD 5.3, with a total market value of HKD 3.16 billion. In terms of news, due to violations in fundraising management, the company has consecutively received warning letters and regulatory letters from the Inner Mongolia Securities Regulatory Bureau and the Shenzhen Stock Exchange. Behind a series of violations, Dongbao Bio-Tech's financial situation is also far from optimistic. In the first three quarters of 2024, the company's operating revenue decreased by 13.82% year-on-year, and the net profit attributable to the parent company fell by 30.43%, with cash flow from operating activities plummeting by more than 70%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments